Handgrip strength as a predictor of prognosis in Japanese patients with congestive heart failure

European Journal of Preventive Cardiology

Volumn 16, Issue 1, 2009, Pages 21-27

  Izawa, Kazuhiro P ^a   Watanabe, Satoshi ^a   Osada, Naohiko ^b   Kasahara, Yusuke ^a   Yokoyama, Hitoshi ^a   Hiraki, Koji ^a   Morio, Yuji ^a   Yoshioka, Satoru ^a   Oka, Koichiro ^c   Omiya, Kazuto ^b  

^a Department of Rehabilitation Medicine ^*  (United States)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c WASEDA UNIVERSITY   (Japan)

Author keywords

congestive heart failure; handgrip strength; male patient; prognosis

Indexed keywords

AGED; ARTICLE; HAND STRENGTH; HEART FAILURE; HUMAN; JAPAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; ADULT; AGE DISTRIBUTION; BODY MASS; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE TEST; EXTENSOR MUSCLE; GRIP STRENGTH; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; JAPANESE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MUSCLE STRENGTH; OBSERVATIONAL STUDY; OXYGEN TENSION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL; UNIVARIATE ANALYSIS; VALVULAR HEART DISEASE;

AGED; HAND STRENGTH; HEART FAILURE; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PROGNOSIS; PROSPECTIVE STUDIES;

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

EID: 65649129667     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32831269a3     Document Type: Article

References (25)

1. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil 2007; 14 (Suppl 2): S1–S113.
2. Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008; 15: 239–246.
3. Osada N, Chaitman BR, Miller LW, Yip D, Cishek MB, Wolford TL, et al Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol 1999; 33: 591–592.
4. Puetz TW, Beasman KM, O'Connor PJ. The effect of cardiac rehabilitation exercise programs on feelings of energy and fatigue: a meta-analysis of research from 1945 to 2005. Eur J Cardiovasc Prev Rehabil 2006; 13: 886–893.
5. Takata Y, Ansai T, Akifusa S, Soh I, Yoshitake Y, Kimura Y, et al Physical fitness and 4-year mortality in an 80-year-old population. J Gerontol 2007; 62A: 851–858.
6. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778–786.
7. Koike A, Itoh H, Kato M, Sawada H, Aizawa T, Fu LT, et al Prognostic power of ventilatory responses during submaximal exercise in patients with chronic heart disease. Chest 2002; 121: 1581–1588.
8. Mandic S, Riess K, Haykowsky MJ. Exercise training for individuals with coronary artery disease of heart failure. Physiother Can 2006; 58: 21–29.
9. Tsuchihashi M, Tsutsui H, Kodama K, Kasagi F, Takeshita A. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure-a study in Fukuoka, Japan. Jpn Circ J 2000; 64: 953–959.
10. Hülsmann M, Quittan M, Berger R, Crevenna R, Springer C, Nuhr M, et al Muscle strength as a predictor of long-term survival in severe congestive heart failure. Eur J Heart Fail 2004; 6: 101–107.
11. Sasaki H, Kasagi F, Yamada M, Fujita S. Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am J Med 2007; 120: 337–342.
12. Jeune B, Skytthe A, Cournil A, Greco V, Gampe J, Berardelli M, et al Handgrip strength among nonagenarians and centenarians in three European regions. J Gerontol A Biol Sci Med Sci 2006; 61: 707–712.
13. Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc 2003; 50: 636–641.
14. Mroszczyk-McDonald A, Savage PD, Ades P. Handgrip strength in cardiac rehabilitation: normative values, interaction with physical function, and response to training. J Cardiopulm Rehabil 2007; 27: 298–302.
15. Hanson P. Clinical exercise testing. In: Blair SN, Painter P, Pate RR, Smith LK, Taylor CB, editors. Resource Manual for Guidelines for Exercise Testing and Prescription. Philadelphia: Lea & Febiger; 1988. pp. 205–222.
16. Izawa K, Hirano Y, Yamada S, Oka K, Omiya K, Iijima S. Improvement in physiological outcomes and health-related quality of life following cardiac rehabilitation in patients with acute myocardial infarction. Circ J 2004; 68: 315–320.
17. Stanek B, Frey B, Hülsmann M, Berger R, Sturm B, Strametz-Juranek J, et al Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 436–442.
18. Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, et al High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000; 36: 1587–1593.
19. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, et al Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003; 9: 29–35.
20. Nyquist-Battie C, Fletcher GF, Fletcher B, Carlson JM, Castello R, Oken K. Upper-extremity exercise training in heart failure. J Cardipulm Rehabil 2007; 27: 42–45.
21. Izawa KP, Oka K, Watane S, Yokoyama H, Hiraki K, Morio Y, et al Gender-related difference in clinical characteristics and physiological and psychosocial outcomes of Japanese patients at entry into phase II cardiac rehabilitation. J Rehabil Med 2008; 40: 225–230.
22. Hambrecht R, Fiehn E, Yu J, Niebauer J, Weigl C, Hilbrich L, et al Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 1997; 29: 1067–1073.
23. Buller N, Jones D, Poole-Wilson P. Direct measurement of skeletal muscle fatigue in patients with chronic heart failure. Br Heart J 1991; 65: 20–24.
24. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93: 210–214.
25. Cicoira M, Bolger AP, Doehner W, Rauchhaus M, Davos C, Sharma R, et al High tumour necrosis factor-α levels are associated with exercise intolerance and neurohumoral activation in chronic heart failure. Cytokine 2001; 15: 80–86.